Chiron receives FDA priority designation for cyclosporine inhalation resolution as new therapy for lung transplant individuals.(Food and Drug Administration): An report from: Transplant News
This digital document is an post from Transplant News, published by Transplant Communications, Inc. on December 31, 2004. The length of the report is 355 words. The page length shown above is based on a standard 300-word page. The report is delivered in HTML format and is obtainable in your Amazon.com
Tidak ada komentar:
Posting Komentar